Synthesis and evaluation of 2-substituted-6-phenyl-4,5-dihydropyridazin-3(2H)-ones as potent inodilators
Open Access
|Dec 2008References
- S. G. Lee, J. J. Kim, D. H. Kweon, Y. J. Kang, S. D. Cho, S. K. Kim and Y. J. Yoon, Recent progress in pyridazin-3(2)-ones chemistry,8 (2004) 1463-1480; DOI: 10.2174/1385272043369818.
- K. Abouzid, M. A. Hakeem, O. Khalil and Y. Maklad, Pyridazinone derivatives: design, synthesis, and in vitro vasorelaxant activity,16 (2008) 382-389; DOI: 10.1016/j.bmc.2007.09.03.
- K. A. M. Abou-Zeid, K. M. Youssef, M. A. Shaaban, F. A. El-Telbany and S. H. Al-Zanfaly, Synthesis of 6-(4-(substituted-amino)phenyl)-4,5-dihydropyridazin-3(2)-ones as potential positive inotropic agents,38 (1998) 319-331.
- T. Wang, Y. Dong, L. C. Wang and Z. Chen, Synthesis and bioactivity of 6-phenyl-4,5-dihydro-3(2H)-pyridazinone derivatives,57 (2007) 641-647; DOI: 10.1002/chin. 200808160.
- C. V. Curran and A. Ross, 6-Phenyl-4,5-dihydro-3(2)-pyridazinones. A series of hypotensive agents,17 (1974) 273-281; DOI: 10.1021/jm 00249a004.
- S. Archan and W. Toller, Levosimendan: current status and future prospects,21 (2008) 78-84; DOI: 10.1097/ACO.0b013e3282 f357a5.
- R. E. Weishaar, D. C. Kobylarz-Singer, R. P. Steffen and H. R. Kaplan, Subclasses of cyclic AMP-specific phosphodiesterase in left ventricular muscle and their involvement in regulating myocardial contractility,61 (1987) 539-547.
- F. F. Owings, M. Fox, C. J. Kowalski and N. H. Baine, An enantioselective synthesis of SK&F 93505, a key intermediate for preparing cardiotonic agents,56 (1991) 1963-1966.
- B. S. Furniss, A. J. Hannaford, P. W. G. Smith and A. R. Tatchell,, in, 5ed. (Ed. A. I. Vogel), Longman Group Ltd, Harlow 1989, pp. 824-1195.
- L. G. Sevillano, C. P. Melero, E. Caballero, F. Tomé, L. Lelièvre, K. Geering, G. Crambert, R. Carrón, M. Medarde and A. San Feliciano, Inotropic activity of hydroindenic amidinohydrazones,45 (2002) 127-136; DOI: 10.1021/jm0109309.
- M. Guerrero, P. Puebla, R. Carrón, M. L. Martín and L. San Román, Vasorelaxant effect of new-clerodane diterpenoids isolated from94 (2004) 185-198; DOI: 10.1016/j.jep. 2004.05.018.
- T. Seki, A. Kanada, T. Nakao, M. Shiraiwa, H. Asano, K. Miyazawa, T. Ishimori, N. Minami, K. Shibata and K. Yasuda, Studies on agents with vasodilator and β-blocking activities. V.Synthesis and pharmacological activity of the optical isomers of TZC-5665,46 (1998) 84-96.
- M. Endoh, Basic and clinical characteristics of PDE 3 inhibitors as cardiotonic agents,21 (2007) 135-139; DOI: 10.1007/s0557-007-6029-z.
Language: English, Croatian
Page range: 393 - 405
Published on: Dec 22, 2008
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2008 Dinesh Kumar, Rosalia Carron, Carmen La Calle, Dharam Jindal, Ranju Bansal, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.